The World Health Organization (WHO) today announced it had invited mpox vaccine manufacturers to submit an Expression of Interest for Emergency Use Listing (EUL).
On August 9, 2024, the WHO stated that the EUL procedure is an emergency use authorization process specifically developed to expedite the availability of unlicensed medical products, such as vaccines, needed in public health emergencies.
This is a time-limited WHO recommendation based on a risk-benefit approach.
Mpox Vaccines May Qualify for Emergency Use Listing
Ticks Are Tiny Lyme Disease Carriers
With nearly 900 species of ticks identified globally, their impact on human health is becoming increasingly concerning. Unfortunately, the northeastern United States has become a prime area for these disease-carrying ticks.
According to a study published by the journal Ticks and Tick-borne Diseases in November 2023, there are 20 tick-borne diseases found in the U.S.
FDA Approves Voranigo for Grade 2 Astrocytoma or Oligodendroglioma
This is the first FDA-approved systemic therapy for patients with a susceptible IDH1 or IDH2 mutation